EXHIBIT 99.1

BLONDER                                                      One Jake Brown Road
TONGUE                                                 Old Bridge, NJ 08857-1000
LABORATORIES                                   (732) 679-4000 Fax (732) 679-4353
[LOGO]                                                     www.blondertongue.com

For Immediate Release:                         Contact: James A. Luksch
May 13, 2004                                            Chairman and
                                                        Chief Executive Officer
                                                        (732) 679-4000



                Blonder Tongue Reports 2004 First Quarter Results
                -------------------------------------------------

OLD BRIDGE, NEW JERSEY, May 13, 2004 - Blonder Tongue Laboratories,  Inc. (AMEX:
"BDR") today  announced its sales and earnings for the first quarter ended March
31, 2004.

Net sales for the first quarter 2004 were $8,529,000  compared to $8,602,000 for
the first quarter 2003.  Reductions in sales in some product  groups were offset
by increased sales in new product groups. Sales of both digital and interdiction
products were down from the comparable period in the prior year. Digital product
sales were  $1,190,000 in the first quarter 2004,  compared to $1,336,000 in the
first quarter 2003,  and  interdiction  product sales were $677,000 in the first
quarter  2004  compared to  $775,000 in the first  quarter  2003.  Products  and
services with  increased  sales  included  telephony  products,  high speed data
products,  and technical services.  Also included in net sales are revenues from
BDR Broadband of $346,000,  increased  from $202,000 in first quarter 2003.  The
Company's net loss was $397,000 for the first three months of 2004 compared to a
net loss of $758,000  for the same period in the prior  year.  Diluted  loss per
share for the first three  months of 2004 was $0.05,  compared to a diluted loss
of $0.10 for the same period in the prior year.

Commenting on the first quarter 2004 results, James A. Luksch,  Chairman,  Chief
Executive Officer said, "Sales activity at the end of the first quarter suggests
that the bottom has been reached and the Company's core business should begin to
rebound,  We expect that the pickup in our core  business  will be  augmented by
increased  sales  activity for our  telephony  and high speed data  products and
services,  which are also  anticipated to contribute  positively to future sales
and earnings.  Unless some unexpected events occur, the Company should return to
profitability in the second quarter. Sales should improve throughout the rest of
2004 resulting in positive performance for the year."

Blonder  Tongue  Laboratories  is a designer,  manufacturer,  and  supplier of a
comprehensive  line of electronics and systems  equipment for the franchised and
private cable television  industries.  The Company has also introduced equipment
and  innovative  solutions  for the  high-speed  transmission  of  data  and the
provision of telephony services in multiple dwelling unit applications.  Founded
in 1950, Blonder Tongue offers a comprehensive  product line and has grown to be
one of the  leaders  in  cable  television  equipment  manufacturing.  For  more
information regarding Blonder Tongue or its products, please visit the Company's
Internet site at  www.blondertongue.com or contact the Company directly at (732)
679-4000.

"Safe Harbor"  Statement under the Private  Securities  Litigation Reform Act of
1995: The information set forth above includes "forward-looking"  statements and
accordingly,  the cautionary  statements  contained in Blonder  Tongue's  Annual
Report and Form 10-K for the year ended  December 31, 2003 (See Item 1: Business
and Item 7:  Management's  Discussion  and Analysis of Financial  Condition  and
Results of  Operations),  and other  filings  with the  Securities  and Exchange
Commission are incorporated herein by reference. The words "believe",  "expect",
"anticipate",   "project",  and  similar  expressions  identify  forward-looking
statements.  Readers  are  cautioned  not  to  place  undue  reliance  on  these
forward-looking  statements,  which reflect management's analysis only as of the
date hereof.  Blonder Tongue  undertakes no obligation to publicly  revise these
forward-looking  statements to reflect events or circumstances  that arise after
the date hereof. Blonder Tongue's actual results may differ from the anticipated
results or other  expectations  expressed in Blonder Tongue's  "forward-looking"
statements.



                        Blonder Tongue Laboratories, Inc.
                    Consolidated Summary of Operating Results
                      (in thousands, except per-share data)
                                   (unaudited)


                                        Three months ended
                                            March 31,
                                       ------------------
                                        2004       2003
                                       ------------------

Net Sales                              $ 8,529    $ 8,602
Gross Profit                             2,941      2,159
Loss from operations                      (122)      (951)
Net loss                                  (397)      (758)
Net loss per share:
   Basic and diluted                    ($0.05)    ($0.10)
Weighted average shares outstanding:
   Basic and diluted                     7,997      7,539



                       Consolidated Summary Balance Sheets
                                 (in thousands)


                                         March 31, 2004   December 31, 2003
                                         --------------   -----------------
                                          (unaudited)

Current assets                               $31,841         $31,376
Property, plant, and equipment, net            6,485           6,652
Total assets                                  47,842          47,990
Current liabilities                            7,778           6,305
Long-term liabilities                          8,501           9,745
Stockholders' equity                          31,563          31,940

Total liabilities and stockholders' equity   $47,842         $47,990


                                        2